ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
67.080,76
2,82%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) News

RVMD

Revolution Medicines (RVMD)

Revolution Medicines Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RVMD
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202422h02GlobeNewswire Inc.Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
01/05/202422h05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024NASDAQ:RVMDRevolution Medicines Inc
09/04/202421h34GlobeNewswire Inc.Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
08/04/202417h36GlobeNewswire Inc.Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
04/04/202422h05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
28/03/202421h05GlobeNewswire Inc.Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024NASDAQ:RVMDRevolution Medicines Inc
05/03/202422h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
05/03/202422h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
05/03/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
04/03/202423h23Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RVMDRevolution Medicines Inc
26/02/202423h04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RVMDRevolution Medicines Inc
26/02/202422h05GlobeNewswire Inc.Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
26/02/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
20/02/202422h05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024NASDAQ:RVMDRevolution Medicines Inc
09/02/202423h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RVMDRevolution Medicines Inc
01/02/202422h05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
24/01/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
22/01/202422h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/01/202420h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
04/01/202413h00GlobeNewswire Inc.Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RVMDRevolution Medicines Inc
20/12/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
20/12/202323h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/12/202300h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
14/12/202323h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
21/11/202300h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
20/11/202322h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
16/11/202320h58Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:RVMDRevolution Medicines Inc
15/11/202322h04Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:RVMDRevolution Medicines Inc
15/11/202302h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/11/202302h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:RVMD

Kürzlich von Ihnen besucht

HITB
INJUSD
Injective Token
BIT
UV4LKY
UniCredit Bank
KUCN
MELOSUSDT
MELOS
BIT
UC3WN1
Unicredit Bank
TSX
LPAY.U
Global X Long Term US Tr...
EU
3856T
3856T
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten